Recent Advances in Mesenchymal Stem/Stromal Cell Processes
A special issue of Bioengineering (ISSN 2306-5354).
Deadline for manuscript submissions: closed (31 July 2024) | Viewed by 280
Special Issue Editor
Interests: stem cell bioprocessing; bioreactor concepts for stem cells; up- and downstream processing for oncolytic measles virus; online monitoring and control of stem cell and viral production processes
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Mesenchymal stem/stromal cells (MSCs) are currently one of the most commonly used cell types in bioengineering and biomedicine. The purpose of this Special Issue is to provide a collection of high-quality research articles and reviews covering the latest knowledge of the development of mesenchymal stem/stromal cell processes. The scope of this Special Issue includes but is not limited to the following topics:
- Manufacturing of stem cells as cell therapy products for human and animal use;
- Manufacturing of stem cells in the context of cultured meat;
- Processes for extracellular vesicle production with stem cells;
- Up- and downstream development for stem cells, including the adaption of existing processes and process intensification;
- Quality-by-design approaches;
- Solutions for manufacturing challenges involved in stem cell processes;
- Theoretical process set-up (bioengineering calculations, CFD simulations);
- Novel bioreactor systems for stem cells;
- Novel or sophisticated analytical methods for stem cells (those regarding process development are preferred);
- Online monitoring tools and process automation for stem cells.
Prof. Dr. Denise Salzig
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mesenchymal stem/stromal cells (MSCs)
- stem cell processes
- bioreactor systems
- extracellular vesicle
- intercellular interactions
- regenerative medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
